Rituximab in the treatment of primary glomerulopathies - our experience.

Vnitrni lekarstvi(2021)

引用 0|浏览0
暂无评分
摘要
Rituximab represents an effective alternative in the treatment of primary glomerulopathies, especially in cases of resistance to standard immunosuppressive therapy, which is shared by the clinical experience presented by us.
更多
查看译文
关键词
Proteinuria,primary glomerulopathy,rituximab
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要